Rupali Jaiswal, Priti Verma, OP Verma, Amresh Gupta, Deepti Upadhyay*.
Goel Institute of Pharmacy and Sciences, Faizabad Road, Lucknow, Uttar Pradesh, India.
REVIEW ARTICLE
Volume 10, Issue 2, Page 59-66.
*Author for correspondence
E-mail: deeptiupadhyaykni1996@gmail.com
DOI: https://doi.org/10.5281/zenodo.7045986.
ABSTRACT
Lung cancer is the world’s second leading cause of death, with an estimated 9.6 million deaths in 2018. Approximately 80% of all lung cancer is caused by non-small cell lung cancer (NSCLC). Due to a lack of early detection and treatment, the incidence rate of lung cancer prognosis remains low. CD4+T-lymphocytes, macrophages, dendritic cells, and natural killer cells are among the immune cells involved in the pathogenesis of lung cancer...
Read More Lung cancer is the world’s second leading cause of death, with an estimated 9.6 million deaths in 2018. Approximately 80% of all lung cancer is caused by non-small cell lung cancer (NSCLC). Due to a lack of early detection and treatment, the incidence rate of lung cancer prognosis remains low. CD4+T-lymphocytes, macrophages, dendritic cells, and natural killer cells are among the immune cells involved in the pathogenesis of lung cancer...
CAS Source Index (CASSI): A division of American Chemical Society
This work is licensed under a